Addition of bevacizumab to vinorelbine-platinum combination is efficacious in heavily pretreated HER2-negative metastatic breast cancer.
I-Wei Ho, Yi-Ru Tseng, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Ta-Chung Chao, & Jiun-I Lai. J Cancer 2025; 16(5):1726–1735.
doi:10.7150/jca.105199
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition.
Kevin Kalinsky et al. (including Jiun-I Lai). J Clin Oncol. 2024 Dec 18: JCO2402086.
doi:10.1200/JCO-24-02086
Real world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma.
Jiun-I Lai, Yu-Ching Peng, Peter Mu-Hsin Chang, et al. Journal of the Chinese Medical Association (2025).
doi:10.1097/JCMA.0000000000001209
2023
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients.
Lai JI, Kuo TH, Huang KJ, Chai LMX, Lee MH, Liu CY, Tsai YF, Huang CC, Tseng LM, Hsu CC, Chao TC. Oncologist. 2023 Nov 23:oyad304.
doi:10.1093/oncolo/oyad304
2022
A Systemic Review of Taxanes and Their Side Effects in Metastatic Breast Cancer.
Jiun-I Lai, Ta-Chung Chao, Chun-Yu Liu, Chi-Cheng Huang, Ling-Ming Tseng. Frontiers in Oncology 2022 Oct 11;12:940239.
doi:10.3389/fonc.2022.940239
IKZF3 amplification frequently occurs in HER2 positive breast cancer and is a potential therapeutic target.
ChihYi Lin, Chung-Jen Yu, Chia-I Shen, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I Lai. Medical Oncology 2022 Sep 30;39(12):242.
doi:10.1007/s12032-022-01812-x
CDK4/6 inhibitors downregulate the ubiquitin conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER+ breast cancer.
Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I Lai. Clinical and Translational Oncology 2022 Aug 2.
2020
Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics.
Jiun-I Lai, Tseng YJ, Chen MH, Huang CF, Chang PM. Front Oncol. 2020 Nov 16;10:561936.
2019
Concomitant Genetic Alterations are associated with worse clinical outcome in EGFR mutant NSCLC patients treated with tyrosine kinase inhibitors.
Chang SC, Lai YC, Chang CY, Huang LK, Chen SJ, Tan KT, Yu PN, Lai JI. Transl Oncol. 2019 Aug 8;12(11):1425–1431.
doi:10.1016/j.tranon.2019.07.008
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH, Chang SC, Lin PC, Yang SH, Lin CC, Lan YT, Lin HH, Lin CH, Lai JI, Liang WY, Lu ML, Yang MH, Chao Y. Oncologist. 2019 Jul 10.
Impact of angiotension I converting enzyme gene I/D polymorphism on running performance, lipid, and biochemical parameters in ultra-marathoners.
Chiu YH, Lai JI, Tseng CY, Wang SH, Li LH, Kao WF, How CK, Chang WH, Hsieh CY. Medicine (Baltimore). 2019 Jul;98(29):e16476.
Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
Jiun-I Lai, Daniel Nachun, Lina Petrosyan, Benjamin Throesch, Erica Campau, Fuying Gao, Kristin K Baldwin, Giovanni Coppola, Joel M. Gottesfeld, Elisabetta Soragni. J Biol Chem. 2019 Feb 8;294(6):1846–1859.
doi:10.1074/jbc.RA118.006515
2018
Reduction in the incidence of pneumonia in elderly patients after hip fracture surgery: An inpatient pulmonary rehabilitation program.
Chang SC, Lai JI, Lu MC, Lin KH, Wang WS, Lo SS, Lai YC. Medicine (Baltimore). 2018 Aug;97(33):e11845.
The Changes of Red Blood Cell Viscoelasticity and Sports Anemia in Male 24-hr Ultra-marathoners.
Liu CH, Tseng YF, Lai JI, Chen YQ, Wang SH, Kao WF, Li LH, Chiu YH, How CK, Chang WH. J Chin Med Assoc 2018 May;81(5):475–481.
doi:10.1016/j.jcma.2017.09.011
2017
Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.
Lai JI, Lai YC, Chen YC, Wang NK, Pan JN, Wang WS, Chang SC. Cancer Gene Ther. 2017 Sep;24(9):373–380.
doi:10.1038/cgt.2017.26
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Chang SC, Lai YC, Chen YC, Wang NK, Pan JN, Wang WS, Lai JI. Asia-Pacific Journal of Clinical Oncology 2017 Nov 10.
doi:10.1111/ajco.12820
Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: Screening with iPSC-derived neuronal cells.
Lai JI, Leman LJ, Ku S, Vickers CJ, Olsen CA, Montero A, Ghadiri MR, Gottesfeld JM. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3289–3293.
doi:10.1016/j.bmcl.2017.06.027
2015
Early changes of the anemia phenomenon in male 100-km ultramarathoners.
Chiu YH, Lai JI, Wang SH, How CK, Li LH, Kao WF, Yang CC, Chen RJ. J Chin Med Assoc. 2015 Feb;78(2):108–13.
2012
Readmission to the intensive care unit: a population-based approach.
Lai JI, Lin HY, Lai YC, Lin PC, Chang SC, Tang GJ. J Formos Med Assoc. 2012 Sep;111(9):504–9.
2011
Acute renal failure in severe pancreatitis: A population-based study.
Lin HY, Lai JI, Lai YC, Lin PC, Chang SC, Tang GJ. Ups J Med Sci. 2011 May;116(2):155–9 (equal contribution).
Successful treatment of gallbladder neuroendocrine carcinoma with combined chemo-radiotherapy: A case report and literature review.
Lin PC, Lai YC, Lai JI, Hsu SY, Wang WS. Int J Clin Pharmacol Ther. 2011 Jun;49(6):403–8.
A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib.
Lin PC, Lai JI, Tzeng CH, Wang WS. Med Oncol. 2011 Mar;28(1):140–50 (equal contribution).
2010
Barotrauma related extensive pneumothorax, pneumomediastinum, and subcutaneous emphysema in a patient with acute respiratory distress syndrome with low tidal volume.
Lai JI, Lin PC, Wang WS, Chang SC, Lai YC. Postgrad Med J. 2010 Sep;86(1019):567–8.
Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy.
Lai JI, Wang WS, Lai YC, Lin PC, Chang SC. Int J Clin Pharmacol Ther 2010 Jul;48(7):425–8.
2009
Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.
Lai JI, Tzeng CH, Chen PM, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. Cancer Sci. 2009 Jul;100(7):1261–6.
Acute hemolysis after receiving oxaliplatin treatment; A case report and literature review.
Lai JI, Wei-Shu Wang. Pharm World Sci 2009 Oct;31(5):538–41.